Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.

Journal of endocrinological investigation - 1 Dec 2024

Borowczyk M, Kaczmarek-Ryś M, Hryhorowicz S, Sypniewski M, Filipowicz D, Dobosz P, Oszywa M, Ruchała M, Ziemnicka K

Abstract excerpt

PURPOSE: Differentiated thyroid cancer (DTC) presents a complex clinical challenge, especially in patients with distant metastases and resistance to standard treatments. This study aimed to investigate the influence of specific genes and their germline single nucleotide polymorphisms (SNPs) linked to both inflammatory processes and other neoplasms on the clinical and pathological characteristics of DTC,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Iodine Radioisotopes

Share to Nod2 Signaling Adaptor Protein

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Thyroidectomy

Source

Open in PubMed Open full text

Identifiers

PMID: 38755492
DOI: 10.1007/s40618-024-02389-0
PMCID: PMC11549118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.PMID 38755492Read ↗

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approachesSemantic proximity Read ↗

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New DrugsSemantic proximity Read ↗

Genome-wide association and expression analyses of programmed cell death provide novel insights into therapeutic targets in differentiated thyroid cancerSemantic proximity Read ↗

Genome-wide association and expression analyses of programmed cell death associated genes provide novel insight into therapeutic target in differentiated thyroid cancerSemantic proximity Read ↗

Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases.Semantic proximity Read ↗

Genome-wide association study on differentiated thyroid cancer.Semantic proximity Read ↗

Global multi-ancestry genetic study elucidates genes and biological pathways associated with thyroid cancer and benign thyroid diseasesSemantic proximity Read ↗

Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023.Semantic proximity Read ↗

Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cellsSemantic proximity Read ↗

TTN mutations predict a poor prognosis in patients with thyroid cancer.Semantic proximity Read ↗

Multi-omics data analysis reveals the complex roles of age in differentiated thyroid cancerSemantic proximity Read ↗

Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.